Visit-to-visit blood pressure variability and risk for progression of cardiovascular and renal diseases

Current Opinion in Nephrology and Hypertension

Volumn 22, Issue 1, 2013, Pages 59-64

  Rossignol, Patrick ^a,b,c,d   Kessler, Michèle ^a,b   Zannad, Faiez ^a,b,c  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c INSERM   (France)

^d Association Lorraine Pour le Traitement de l'Insuffisance Ré Nale   (France)

Author keywords

antihypertensive treatment; cardiovascular prognosis; target organ damage; visit to visit blood pressure variability

Indexed keywords

BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR DISEASE; DISEASE COURSE; HOME BLOOD PRESSURE; HUMAN; KIDNEY DISEASE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; REVIEW; VISIT TO VISIT BLOOD PRESSURE VARIABILITY;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; HUMANS; HYPERTENSION; KIDNEY DISEASES; OFFICE VISITS; RISK FACTORS;

EID: 84871789956     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32835b489f     Document Type: Review

References (27)

1. Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010; 375:938-948.
2. Mancia G. Prognostic value of long-term blood pressure variability: the evidence is growing. Hypertension 2011; 57:141-143.
3. Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-tovisit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375:895-905.
4. Rothwell PM, Howard SC, Dolan E, et al. Effects of beta blockers and calciumchannel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol 2010; 9:469-480.
5. Muntner P, Shimbo D, Tonelli M, et al. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension 2011; 57:160-166.
6. Shimbo D, Newman JD, Aragaki AK, et al. Association between annual visit-tovisit blood pressure variability and stroke in postmenopausal women: data from the Women's Health Initiative. Hypertension 2012; 60:625-630.
7. Hsieh YT, Tu ST, Cho TJ, et al. Visit-to-visit variability in blood pressure strongly predicts all-cause mortality in patients with type 2 diabetes: a 5.5-year prospective analysis. Eur J Clin Invest 2012; 42:245-253.
8. Zannad F, Kessler M, Lehert P, et al. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int 2006; 70:1318-1324.
9. Rossignol P, Cridlig J, Lehert P, et al. Visit-to-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis: insights from FOSIDIAL. Hypertension 2012; 60:339-346.
10. Kilpatrick ES, Rigby AS, Atkin SL. The role of blood pressure variability in the development of nephropathy in type 1 diabetes. Diabetes Care 2010; 33:2442-2447.
11. Diaz KM, Veerabhadrappa P, Kashem MA, et al. Relationship of visit-to-visit and ambulatory blood pressure variability to vascular function in African Americans. Hypertens Res 2012; 35:55-61.
12. Okada H, Fukui M, Tanaka M, et al. Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes. Atherosclerosis 2012; 220:155-159.
13. Kawai T, Ohishi M, Kamide K, et al. The impact of visit-to-visit variability in blood pressure on renal function. Hypertens Res 2012; 35:239-243.
14. Masugata H, Senda S, Murao K, et al. Visit-to-visit variability in blood pressure over a 1-year period is a marker of left ventricular diastolic dysfunction in treated hypertensive patients. Hypertens Res 2011; 34:846-850.
15. Nagai M, Hoshide S, Ishikawa J, et al. Visit-to-visit blood pressure variations: new independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease. J Am Soc Hypertens 2011; 5:184-192.
16. Nagai M, Hoshide S, Ishikawa J, et al. Visit-to-visit blood pressure variations: new independent determinants for cognitive function in the elderly at high risk of cardiovascular disease. J Hypertens 2012; 30:1556-1563.
17. Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis. Circulation 2012; 126:569-578.
18. Krakoff LR. Fluctuation: does blood pressure variability matter? Circulation 2012; 126:525-527.
19. Howard SC, Rothwell PM. Reproducibility of measures of visit-to-visit variability in blood pressure after transient ischaemic attack or minor stroke. Cerebrovasc Dis 2009; 28:331-340.
20. Muntner P, Joyce C, Levitan EB, et al. Reproducibility of visit-to-visit variability of blood pressure measured as part of routine clinical care. J Hypertens 2011; 29:2332-2338.
21. Muntner P, Levitan EB, Reynolds K, et al. Within-visit variability of blood pressure and all-cause and cardiovascular mortality among US adults. J Clin Hypertens (Greenwich) 2012; 14:165-171.
22. Matsui Y, O'Rourke MF, Hoshide S, et al. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-byday variability of home blood pressure: the Japan Combined Treatment with Olmesartan and a Calcium-channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study. Hypertension 2012; 59:1132-1138.
23. Ushigome E, Fukui M, Hamaguchi M, et al. The coefficient variation of home blood pressure is a novel factor associated with macroalbuminuria in type 2 diabetes mellitus. Hypertens Res 2011; 34:1271-1275.
24. Kikuya M, Ohkubo T, Metoki H, et al. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama Study. Hypertension 2008; 52:1045-1050.
25. Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment. J Hypertens 2012; 30:1241-1251.
26. Webb AJ, Rothwell PM. Blood pressure variability and risk of new-onset atrial fibrillation: a systematic review of randomized trials of antihypertensive drugs. Stroke 2010; 41:2091-2093.
27. Webb AJ, Rothwell PM. Effect of dose and combination of antihypertensives on interindividual blood pressure variability: a systematic review. Stroke 2011; 42:2860-2865.